These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 16800041

  • 1. Humoral immune responses against minute virus of mice vectors.
    Lang SI, Giese NA, Rommelaere J, Dinsart C, Cornelis JJ.
    J Gene Med; 2006 Sep; 8(9):1141-50. PubMed ID: 16800041
    [Abstract] [Full Text] [Related]

  • 2. B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression.
    Raykov Z, Savelyeva L, Balboni G, Giese T, Rommelaere J, Giese NA.
    J Virol; 2005 Mar; 79(6):3517-24. PubMed ID: 15731246
    [Abstract] [Full Text] [Related]

  • 3. Oncolytic murine autonomous parvovirus, a candidate vector for glioma gene therapy, is innocuous to normal and immunocompetent mouse glial cells.
    Abschuetz A, Kehl T, Geibig R, Leuchs B, Rommelaere J, Régnier-Vigouroux A.
    Cell Tissue Res; 2006 Sep; 325(3):423-36. PubMed ID: 16699801
    [Abstract] [Full Text] [Related]

  • 4. Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection.
    Grekova SP, Raykov Z, Zawatzky R, Rommelaere J, Koch U.
    Cancer Gene Ther; 2012 Jul; 19(7):468-75. PubMed ID: 22539062
    [Abstract] [Full Text] [Related]

  • 5. A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.
    Dupont F, Karim A, Dumon JC, Mine N, Avalosse B.
    Gene Ther; 2001 Jun; 8(12):921-9. PubMed ID: 11426332
    [Abstract] [Full Text] [Related]

  • 6. Circumvention of vector-specific neutralizing antibody response by alternating use of human and non-human adenoviruses: implications in gene therapy.
    Moffatt S, Hays J, HogenEsch H, Mittal SK.
    Virology; 2000 Jun 20; 272(1):159-67. PubMed ID: 10873758
    [Abstract] [Full Text] [Related]

  • 7. An extension of the Minute Virus of Mice tissue tropism.
    Etingov I, Itah R, Mincberg M, Keren-Naus A, Nam HJ, Agbandje-McKenna M, Davis C.
    Virology; 2008 Sep 30; 379(2):245-55. PubMed ID: 18684479
    [Abstract] [Full Text] [Related]

  • 8. Experimentally induced infection with autonomous parvoviruses, minute virus of mice and H-1, in the African multimammate mouse (Mastomys coucha).
    Haag A, Wayss K, Rommelaere J, Cornelis JJ.
    Comp Med; 2000 Dec 30; 50(6):613-21. PubMed ID: 11200567
    [Abstract] [Full Text] [Related]

  • 9. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver.
    Yang Y, Greenough K, Wilson JM.
    Gene Ther; 1996 May 30; 3(5):412-20. PubMed ID: 9156802
    [Abstract] [Full Text] [Related]

  • 10. The infectivity and lytic activity of minute virus of mice wild-type and derived vector particles are strikingly different.
    Lang SI, Boelz S, Stroh-Dege AY, Rommelaere J, Dinsart C, Cornelis JJ.
    J Virol; 2005 Jan 30; 79(1):289-98. PubMed ID: 15596824
    [Abstract] [Full Text] [Related]

  • 11. Repeated administration of adenovector in the eye results in efficient gene delivery.
    Hamilton MM, Brough DE, McVey D, Bruder JT, King CR, Wei LL.
    Invest Ophthalmol Vis Sci; 2006 Jan 30; 47(1):299-305. PubMed ID: 16384977
    [Abstract] [Full Text] [Related]

  • 12. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
    Ye X, Robinson MB, Pabin C, Batshaw ML, Wilson JM.
    Gene Ther; 2000 Oct 30; 7(20):1761-7. PubMed ID: 11083498
    [Abstract] [Full Text] [Related]

  • 13. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
    Kim SA, Liang CM, Cheng IC, Cheng YC, Chiao MT, Tseng CJ, Lee F, Jong MH, Tao MH, Yang NS, Liang SM.
    J Gene Med; 2006 Sep 30; 8(9):1182-91. PubMed ID: 16927362
    [Abstract] [Full Text] [Related]

  • 14. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity.
    Yoshizaki M, Hironaka T, Iwasaki H, Ban H, Tokusumi Y, Iida A, Nagai Y, Hasegawa M, Inoue M.
    J Gene Med; 2006 Sep 30; 8(9):1151-9. PubMed ID: 16841365
    [Abstract] [Full Text] [Related]

  • 15. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
    Sim AC, Lin W, Tan GK, Sim MS, Chow VT, Alonso S.
    Vaccine; 2008 Feb 26; 26(9):1145-54. PubMed ID: 18243432
    [Abstract] [Full Text] [Related]

  • 16. Immune responses to repetitive adenovirus-mediated gene transfer and restoration of gene expression by cyclophosphamide or etoposide.
    Hamada K, Sakaue M, Sarkar A, Buchl S, Satterfield W, Keeling M, Sastry J, Roth JA, Follen M.
    Gynecol Oncol; 2005 Dec 26; 99(3 Suppl 1):S177-86. PubMed ID: 16214207
    [Abstract] [Full Text] [Related]

  • 17. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS, Kim JH, Choi KJ, Choi IK, Kim H, Cho S, Cho BC, Yun CO.
    Clin Cancer Res; 2006 Oct 01; 12(19):5859-68. PubMed ID: 17020994
    [Abstract] [Full Text] [Related]

  • 18. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. II. Antibody response to viral envelope antigens.
    Vlug A, Melief CJ, de Bruyne C, Schoenmakers H, Molenaar JL.
    J Natl Cancer Inst; 1980 May 01; 64(5):1191-8. PubMed ID: 6245302
    [Abstract] [Full Text] [Related]

  • 19. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
    Grueso E, Sánchez-Martínez C, Calvo-López T, de Miguel FJ, Blanco-Menéndez N, Fernandez-Estevez M, Elizalde M, Sanchez J, Kourani O, Martin D, Tato A, Guerra M, Andrés G, Almendral JM.
    J Virol; 2019 Oct 01; 93(19):. PubMed ID: 31315994
    [Abstract] [Full Text] [Related]

  • 20. In vitro expression of full-length and truncated bovine respiratory syncytial virus G proteins and their antibody responses in BALB/c mice.
    Brady RP, Topliff CL, Kelling CL.
    Vaccine; 2004 Sep 09; 22(27-28):3762-8. PubMed ID: 15315857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.